CCTG MA40: Double-blind placebo controlled phase III trial of Fulvestrant and  Ipatasertib for advanced HER-2 negative and estrogen receptor positive (ER+) breast cancer post first line CDK 4/6 and aromatase inhibitor therapy (FINER)
Fulvestrant;Ipatasertib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: CCTG MA40: Double-blind placebo controlled phase III trial of Fulvestrant and  Ipatasertib for advanced HER-2 negative and estrogen receptor positive (ER+) breast cancer post first line CDK 4/6 and aromatase inhibitor therapy (FINER) ### Output: Fulvestrant;Ipatasertib